ADB-CHMINACA : Report on the risk assessment of N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances [PDF]
ADB-CHMINACA : Report on the risk assessment of N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances [PDF]
European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Lisbon: EMCDDA, 2018
83 p.
Risk assessments ;22
drugs - Nieuwe Psychoactieve Stoffen - productinformatie - onderzoeksrapporten - risicoschatting -
Exemplaarinformatie:
E-bron
Online link:
http://www.google.com/search?q=Report-on-the-risk-assessment-of-N-1-amino-3-3dimethyl-1-oxobutan-2-yl Kies "toon normaal" voor een toonformaat met hyperlinks.
European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Lisbon: EMCDDA, 2018
83 p.
Risk assessments ;22
drugs - Nieuwe Psychoactieve Stoffen - productinformatie - onderzoeksrapporten - risicoschatting -
Exemplaarinformatie:
E-bron
Online link:
http://www.google.com/search?q=Report-on-the-risk-assessment-of-N-1-amino-3-3dimethyl-1-oxobutan-2-yl Kies "toon normaal" voor een toonformaat met hyperlinks.